Ampicillin-resistant and vancomycin-susceptible Enterococcus faecium bacteremia: a clinical narrative review
D Echeverria-Esnal, L Sorli… - Expert Review of Anti …, 2023 - Taylor & Francis
Introduction Enterococcus faecium is a commensal microorganism that can cause infections
such as bacteremia. Incidence of ampicillin-resistant and vancomycin-susceptible E …
such as bacteremia. Incidence of ampicillin-resistant and vancomycin-susceptible E …
[HTML][HTML] Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper
J Turnidge, G Kahlmeter, R Cantón… - Clinical Microbiology …, 2020 - Elsevier
Scope This position paper describes the view adopted by EUCAST on the role of
daptomycin in the treatment of serious infections caused by Enterococcus species …
daptomycin in the treatment of serious infections caused by Enterococcus species …
[HTML][HTML] Colistin plus sulbactam or fosfomycin against carbapenem-resistant Acinetobacter baumannii: improved efficacy or decreased risk of nephrotoxicity?
W Saelim, D Changpradub, S Thunyaharn… - Infection & …, 2021 - ncbi.nlm.nih.gov
Background Acinetobacter baumannii has been recognized as a cause of nosocomial
infection. To date, polymyxins, the last-resort therapeutic agents for carbapenem-resistant A …
infection. To date, polymyxins, the last-resort therapeutic agents for carbapenem-resistant A …
Daptomycin versus Glycopeptides for the Treatment of Enterococcus faecium Bacteraemia: A Cohort Study
D Echeverria-Esnal, L Sorli, N Prim, C Martin-Ontiyuelo… - Antibiotics, 2021 - mdpi.com
Background: Ampicillin resistant and glycopeptide susceptible Enterococcus faecium
bloodstream infection (GSEF-BSI) incidence has risen. However, the treatment of choice …
bloodstream infection (GSEF-BSI) incidence has risen. However, the treatment of choice …
[HTML][HTML] Optimizing the dosing regimens of tigecycline against vancomycin-resistant enterococci in the treatment of Intra-abdominal and skin and soft tissue infections
W Santimaleeworagun, J Hemapanpairoa… - Infection & …, 2020 - ncbi.nlm.nih.gov
Tigecycline was previously considered to have activity against vancomycin-resistant
Enterococcus (VRE) isolates, but the optimal dose was not clarified. Thus, this study …
Enterococcus (VRE) isolates, but the optimal dose was not clarified. Thus, this study …
Verification of a novel approach to predicting effects of antibiotic combinations: In vitro dynamic model study with daptomycin and gentamicin against Staphylococcus …
MV Golikova, EN Strukova, YA Portnoy, SH Zinner… - Antibiotics, 2020 - mdpi.com
To explore whether susceptibility testing with antibiotic combinations at pharmacokinetically
derived concentration ratios is predictive of the antimicrobial effect, a Staphylococcus aureus …
derived concentration ratios is predictive of the antimicrobial effect, a Staphylococcus aureus …
[HTML][HTML] Development of a Magnetic Bead-Based Method for Specific Detection of Enterococcus faecalis Using C-Terminal Domain of ECP3 Phage Endolysin
YJ Choi, S Kim, J Kim - Journal of Microbiology and Biotechnology, 2023 - ncbi.nlm.nih.gov
Bacteriophage endolysins are peptidoglycan hydrolases composed of cell binding domain
(CBD) and an enzymatically active domain. A phage endolysin CBD can be used for …
(CBD) and an enzymatically active domain. A phage endolysin CBD can be used for …
Safety of Prolonged Thrice-weekly High Dose Daptomycin in a Hemodialysis Patient with Prosthetic Valve Endocarditis
M Bosco, N Baalbaki - JAPhA Pharmacotherapy, 2024 - Elsevier
Background Daptomycin (DAP) is a cyclic lipopeptide antibiotic with in vitro, concentration-
dependent bactericidal activity against many clinically relevant gram-positive organisms …
dependent bactericidal activity against many clinically relevant gram-positive organisms …
[PDF][PDF] Resistencia a antimicrobianos de última línea en bacterias procedentes de dos hospitales del norte de España
C Rodríguez Lucas - 2021 - digibuo.uniovi.es
RESUMEN (en español) Las bacterias resistentes a antibióticos suponen una seria
amenaza para la salud pública, especialmente cuando afectan a antimicrobianos de última …
amenaza para la salud pública, especialmente cuando afectan a antimicrobianos de última …
Daptomycin Use in Adult Inpatients at KHSC; A Drug Use Evaluation
K Carson, S McKenna - tspace.library.utoronto.ca
Daptomycin was approved by Health Canada (HC) in 2007 for the treatment of complicated
skin and skin structure infections (CSSSIs) at 4 mg/kg/day, and for Staphylococcus aureus …
skin and skin structure infections (CSSSIs) at 4 mg/kg/day, and for Staphylococcus aureus …